Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective open-label study of Go-sha-jinki-gan in frailty and pre-frailty
jRCTs051190072Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jun 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial of goshajinkigan in Fragility, sponsored by Japan Agency for Medical Research and Development. Primary endpoints: Change in hand grip strength, Change in two-step test and 2 more. Started Jun 2022; status: completed.
02
Drugs
goshajinkigan
03
Conditions
Fragility
Beyond the preview
Go deeper on jRCTs051190072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190072.